NYSE:HAEMedical Equipment
Haemonetics (HAE) Could Be 10% Undervalued On Its Margin Expansion Story
Haemonetics (HAE) has drawn attention after recent share price moves, including a gain of about 7% over the past month and roughly 26% over the past 3 months. These changes are prompting closer examination of its fundamentals.
See our latest analysis for Haemonetics.
At a share price of $77.86, Haemonetics shows recent momentum with a 30 day share price return of 7.05% and a 90 day share price return of 26.36%. This is set against a more modest 1 year total shareholder return of 7.32% and a 3...